Summary
25T-2-NBOMe is a highly potent NBOMe derivative active in the microgram range. This compound is the N-(2-methoxybenzyl) derivative of 2C-T-2 and exhibits significantly increased potency compared to its parent compound. Accurate measurement with a 0.001 g (milligram) scale or volumetric dosing is essential; visual dosing is extremely dangerous and responsible for most NBOMe hospitalisations and fatalities. Acute risks include peripheral vasoconstriction, hypertension, tachycardia, hyperthermia, agitation, and seizures at high doses. Several fatalities have been reported within the NBOMe series from dose confusion and insufflation.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Sublingual | 100-300ug | 300-600ug | 600-1000ug | 1000ug+ |
| Buccal | 100-300ug | 300-600ug | 600-1000ug | 1000µg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Sublingual | 15-45 min | 30-60 min | 1-3 hrs | 3-6 hrs | 2-10 hrs | 360-0 min |
| Buccal | 15-45 min | 30-60 min | 1-3 hrs | 3-6 hrs | 2-10 hrs | 360-0 min |
| Insufflated | 5-15 min | 15-30 min | 1-3 hrs | 3-6 hrs | 2-10 hrs | 360-0 min |
Tolerance
Build-up
develops rapidly after a single use (serotonergic psychedelic)
Reset
7–14 days for baseline
Effects
Positive
- Stimulation
- Physical euphoria
Negative
- Vasoconstriction
- Nausea
- Increased heart rate
- Temperature regulation suppression
- Pupil dilation
- Insomnia
- Mouth numbing
- Sedation
Positive
- Mild euphoria
- Synesthesia
- Analysis enhancement
- Euphoria
- Conceptual thinking
Negative
- Anxiety
- Confusion
- Memory suppression
- Motor control loss
- Time distortion
Positive
- Visual enhancement
- Colour enhancement
- Pattern recognition enhancement
- Visual geometry
- Tracers
- Tactile enhancement
- Color enhancement
- Increased music appreciation
Negative
- Drifting
- Auditory distortion